Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company targeting the biotechnology and life sciences sector. The SPAC filed an 8-K with the Securities and Exchange Commission on June 17, 2022, under accession number 0001213900-22-033589, marking a material event during its active deal-search period. The vehicle was structured to identify and complete a business combination with a target operating within biotech or adjacent healthcare verticals, reflecting the broader wave of life sciences-focused SPAC formation seen in the early 2020s. Sponsor details were not reflected in the available filing data. Sign up on SpacDesk to access complete filing history, sponsor profiles, and real-time status tracking for BIOT and the full SPAC universe.